Weixiang Liu

Characteristics associated with efficacy of hypoxia-inducible factor-prolyl hydroxylase inhibitors in renal anemia patients: a retrospective cohort study

Hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) are novel drugs used to treat renal anemia patients.However, their efficacy in elevating hemoglobin levels varies among patients. We aimed to identify characteristics that could influence hemoglobin level in renal...